吸入器对环境的影响:西班牙可持续处方实践的框架
Noé Garin1,2,3, Borja Zarate-Tamames4,5, Unax Lertxundi6
1Department of Pharmacy, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain ngarin@santpau.cat.
European journal of hospital pharmacy : science and practice
|January 9, 2025
概括
减少吸入器对环境的影响至关重要. 从压力计量剂量吸入器 (pMDIs) 转换为干粉吸入器 (DPIs),可以显著减少碳排放,提供可持续的医疗保健解决方案.
科学领域:
- 环境健康 环境健康
- 药物经济学 药物经济学
- 公共卫生政策 公共卫生政策
背景情况:
- 医疗保健部门对全球温室气体排放作出了重大贡献.
- 吸入器,特别是压力计量剂量吸入器 (pMDIs),被确定为这种环境足迹的主要贡献者.
- 在医疗保健系统中,越来越需要解决医疗器械对环境的影响.
研究的目的:
- 制定一个框架,以减少西班牙吸入器使用的环境足迹.
- 实施更绿色的吸入器处方做法.
- 创建一个决策工具,整合吸入器选择的临床和环境标准.
主要方法:
- 组建一个多学科工作组 (药剂师,肺病学家,环境专家).
- 创建一个关于西班牙可用的吸入器对环境影响的综合数据库.
- 制定决策算法和情景预测,以便过渡到更可持续的吸入器类型.
主要成果:
- 在不同类型的吸入器的碳足迹中发现了显著的变化,pMDIs的排放量最高.
- 10%的转变从pMDIs到干粉吸入器 (DPI) 可以减少二氧化碳排放量约4万/年.
- 决策算法成功地整合了临床和环境因素,以指导可持续的吸入器选择.
结论:
- 将环境标准纳入吸入器处方是减少医疗保健碳足迹的关键.
- 在临床上适当的情况下,从pMDIs过渡到DPIs,在不损害患者健康的情况下,提供了相当大的环境效益.
- 开发的算法作为医疗保健专业人员平衡临床疗效与环境可持续性的实用工具.
相关概念视频
01:17Drugs Used in Lower Respiratory Disorders: Overview
349
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
349
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
231
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
231
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
217
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
217
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:30Asthma-IV: Nursing Management
3.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.0K
01:23Inhaled Medications
237
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
237